European Journal of Pediatrics

, Volume 146, Issue 3, pp 305–308 | Cite as

Acute intermittent porphyria —an unusual cause of “surgical” abdomen

Response to proparanolol therapy
  • I. Srugo
  • E. Said
  • S. Korman
  • M. Jaffe
Case Reports


We report a case of Acute Intermittent Porphyria which presented with acute abdominal distress, autonomic dysfunction and laboratory abnormalities. The treatment is discussed with special emphasis on the effect of large doses of Propranolol.

Key words

Acute intermittent porphyria Treatment Propranolol 



acute intermittent porphyria


δ-aminolevulinic acid










Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Anderson KE (1979) Nutrition and oxidative drug metabolism in man: relative influence of dietary lipids, carbohydrates and protein. Clin Pharmacol Ther 26:493Google Scholar
  2. 2.
    Atsmon A, Blum I, Fischl J (1972) Treatment of an acute attack of variegata porphyria with Propranolol. S Afr Med J 46: 311Google Scholar
  3. 3.
    Beal MF (1977) Catecholamine uptake accumulation and release in acute porphyria. J Clin Invest 60:1141Google Scholar
  4. 4.
    Beattie AD (1973) Acute intermittent porphyria: response of tachycardia and hypertension to propranolol. Br Med J 3:257Google Scholar
  5. 5.
    Blum I, Atsmon A (1976) Reduction of porphyrin excretion in porphyria variegata by propranolol. S Aft Med J 50:898Google Scholar
  6. 6.
    Blum I, Schonfeld N, Atsmon A (1973) The effect ofDl-propranolol on deltaaminolevulinic acid synthetase activity and urinary excretion of porphyrins in allylisopropylocetamide induced experimental porphyria. Biochim Biophys Acta 320:242Google Scholar
  7. 7.
    Cavanah JB (1965) On the nature of the peripheral nerve lesions associated with acute intermittent porphyria. J Neurol Neurosurg Psychiatry 28:320Google Scholar
  8. 8.
    Eales L (1979) Porphyria and the dangerous life-threatening drugs. S Afr Med J 56:914Google Scholar
  9. 9.
    Flesher BF (1967) Acute intermittent porphyria: effect of diet and griseofulvin. Medicine (Baltimore) 46:217Google Scholar
  10. 10.
    Held H (1976) Effect of the female sexual cycle on the activity of delta-aminolevulinic acid synthase in rat liver. Eur J Clin Invest 6:411Google Scholar
  11. 11.
    Lama N (1979) Hematin therapy for acute porphyria. Medicine (Baltimore) 58:252Google Scholar
  12. 12.
    Mauzerall D (1956) The occurrence and determination of delta-aminolevulinic acid and porphobilinogen in urine. J Biol Chem 219:435Google Scholar
  13. 13.
    Meyer VA (1972) Intermittent acute porphyria: demonstration of a genetic effect in porphobilinogen metabolism. N Engl J Med 286:1277Google Scholar
  14. 14.
    Penlorth MG (1960) Oral contraceptive agents and the management of acute intermittent porphyria. JAMA 194:1037Google Scholar
  15. 15.
    Ridley A (1975) Porphyric neuropathy. In: Dyck DJ, Thomas PK, Lambert GH (eds) Peripheral neuropathy, vol 2. Saunders, Philadelphia, p 947Google Scholar
  16. 16.
    Rifkind AB (1974) Stimulators and inhibitors of hepatic porphyria formation in human serum. J Clin Invest 53:1167Google Scholar
  17. 17.
    Shanle YC (1969) Effect of ethanol on liver delta-aminolevulinate synthetase activity and urinary porphyrin excretion in symptomatic porphyria. Br J Haematol 17:389Google Scholar
  18. 18.
    Stein JA (1970) Acute intermittent porphyria: a clinical and biochemical study of 46 patients. Medicine (Baltimore) 49:1Google Scholar
  19. 19.
    Waldenstrom J (1939) Neurological symptoms caused by so-called acute porphyria. Acta Psychiatr Neurolog 14:375Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • I. Srugo
    • 1
    • 2
  • E. Said
    • 1
    • 2
  • S. Korman
    • 1
    • 2
  • M. Jaffe
    • 1
    • 2
  1. 1.Department of PediatricsHaifa Medical Center (Rothschild)HaifaIsrael
  2. 2.Faculty of MedicineTechnion — Israel Institute of TechnologyHaifaIsrael

Personalised recommendations